Epicrispr raises $90M to rewrite treatment of rare muscle disease
Epicrispr Biotechnologies has raised $90 million in a series C round backed by investors including Sanofi Ventures, positioning the biotech to advance a pipeline of epigenetic medi...
Search fresh public links, source activity, and ready-to-use post angles for Epiq.
Fresh curated links around Epiq are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Epicrispr Biotechnologies has raised $90 million in a series C round backed by investors including Sanofi Ventures, positioning the biotech to advance a pipeline of epigenetic medi...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.